Trial Review

Technical difficulties have been reported by some users of the search function and is being investigated by technical staff. Thank you for your patience and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT01849367




Registration number
NCT01849367
Ethics application status
Date submitted
5/05/2013
Date registered
8/05/2013
Date last updated
17/09/2015

Titles & IDs
Public title
Trial of Bilateral tDCS for Depression
Scientific title
Secondary ID [1] 0 0
HC13052
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Depression 0 0
Condition category
Condition code
Mental Health 0 0 0 0
Depression

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Eldith Neuroconn tDCS device

Experimental: Active tDCS (1) -

Active Comparator: Active tDCS (2) -


Treatment: Devices: Eldith Neuroconn tDCS device
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Montgomery Asberg Depression Rating Scale for Depression (MADRS)
Timepoint [1] 0 0
4 weeks
Secondary outcome [1] 0 0
Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR)
Timepoint [1] 0 0
4 weeks

Eligibility
Key inclusion criteria
1. Participant meets criteria for a DSM-IV Major Depressive episode.

2. MADRS score of 20 or more.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Diagnosis (as defined by DSM-IV) of: any psychotic disorder (lifetime); eating
disorder (current or within the past year); obsessive compulsive disorder (lifetime);
post-traumatic stress disorder (current or within the past year); mental retardation.

2. History of drug or alcohol abuse or dependence (as per DSM-IV criteria) within the
last 3 months (except nicotine and caffeine).

3. Inadequate response to ECT in the current episode of depression.

4. Participant is on regular benzodiazepine medication which is not clinically
appropriate to discontinue.

5. Participant requires a rapid clinical response due to inanition, psychosis or high
suicide risk.

6. Neurological disorder or insult, e.g., recent stroke (CVA), which places participant
at risk of seizure or neuronal damage with tDCS.

7. Participant has metal in the cranium, skull defects, or skin lesions on scalp (cuts,
abrasions, rash) at proposed electrode sites.

8. Female participant who is pregnant, or of child-bearing age, sexually active and not
using reliable contraception (urine test for pregnancy will be used).

9. Participants who are not fluent in English will not be included in the trial for
safety reasons.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 1/Phase 2
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/05/2013
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/07/2015
Sample size
Target
Accrual to date
Final
4
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Black Dog Institute / University of New South Wales - Sydney
Recruitment postcode(s) [1] 0 0
2031 - Sydney

Funding & Sponsors
Primary sponsor type
Other
Name
The University of New South Wales
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Transcranial direct current stimulation (tDCS) is a novel treatment approach for depression
that has shown promising efficacy in four recent double-blind, randomized, sham-controlled
trials (RCT) and a meta-analysis. Mood, cognitive test performance and biomarkers will be
measured during the trial.
Trial website
https://clinicaltrials.gov/ct2/show/NCT01849367
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries